Target intelligence / Profile preview

Activated platelet procoagulant phospholipid surface (APPS)

Target
APPS
Molecular classification
Biological membrane surface, Phospholipid bilayer, Procoagulant complex
01

Overview

The activated platelet procoagulant phospholipid surface is a critical physiological platform for the blood coagulation cascade. Upon activation by stimuli such as thrombin or collagen, platelets undergo a loss of membrane asymmetry, translocating negatively charged phospholipids—primarily phosphatidylserine—from the inner to the outer leaflet of the plasma membrane (Zwaal et al., 2005, Blood). This exposed anionic surface serves as a high-affinity scaffold for the assembly of vitamin K-dependent coagulation factor complexes, including the tenase and prothrombinase complexes, via calcium-dependent bridges (Heemskerk et al., 2013, JTH). By concentrating these factors in close proximity, the surface accelerates the rate of thrombin generation by several orders of magnitude compared to solution-phase reactions (Lentz, 2003, Review). Consequently, this surface is a focal point for thrombotic diseases and a key site of action for various anticoagulant therapies that either inhibit the factors bound to it or mask the surface itself to prevent clot propagation (StatPearls, 2023).

Other names
Procoagulant platelet surfacePhosphatidylserine-exposed membraneAnionic phospholipid surfaceActivated platelet membrane
02

Mechanism of action

Provides a catalytic anionic scaffold that facilitates the calcium-mediated binding and assembly of the tenase (Factors IXa/VIIIa) and prothrombinase (Factors Xa/Va) complexes, thereby accelerating thrombin generation.

03

Biological functions

Blood coagulationHemostasisThrombus formationEnzyme complex assemblyCell signaling
04

Disease associations

ThrombosisMyocardial infarctionStrokeAntiphospholipid syndromeDisseminated intravascular coagulation
05

Safety considerations

HemorrhageBleeding diathesisThrombocytopeniaImpaired wound healing
06

Interacting drugs

Annexin A5

7 more in the full profile.

07

Biomarkers

Annexin V bindingProthrombin fragment 1+2Platelet-derived microparticles (PMPs)P-selectin (CD62P) expression

Beyond the preview

Go deeper on Activated platelet procoagulant phospholipid surface (APPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activated platelet procoagulant phospholipid surface (APPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call